25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

D. Western Therapeutics Institute Inc
Buy, Hold or Sell?

Let's analyze D. Western Therapeutics Institute Inc together

I guess you are interested in D. Western Therapeutics Institute Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of D. Western Therapeutics Institute Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about D. Western Therapeutics Institute Inc

I send you an email if I find something interesting about D. Western Therapeutics Institute Inc.

1. Quick Overview

1.1. Quick analysis of D. Western Therapeutics Institute Inc (30 sec.)










1.2. What can you expect buying and holding a share of D. Western Therapeutics Institute Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€33.70
Expected worth in 1 year
€-28.84
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
€-62.54
Return On Investment
-4,666.9%

For what price can you sell your share?

Current Price per Share
€1.34
Expected price per share
€1.31 - €1.42
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of D. Western Therapeutics Institute Inc (5 min.)




Live pricePrice per Share (EOD)
€1.34
Intrinsic Value Per Share
€-197.41 - €-65.52
Total Value Per Share
€-163.71 - €-31.82

2.2. Growth of D. Western Therapeutics Institute Inc (5 min.)




Is D. Western Therapeutics Institute Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.3b$1.9b-$619.4m-46.4%

How much money is D. Western Therapeutics Institute Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.1m-$2.7m-$2.4m-47.1%
Net Profit Margin-189.7%-95.9%--

How much money comes from the company's main activities?

2.3. Financial Health of D. Western Therapeutics Institute Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of D. Western Therapeutics Institute Inc?

Welcome investor! D. Western Therapeutics Institute Inc's management wants to use your money to grow the business. In return you get a share of D. Western Therapeutics Institute Inc.

First you should know what it really means to hold a share of D. Western Therapeutics Institute Inc. And how you can make/lose money.

Speculation

The Price per Share of D. Western Therapeutics Institute Inc is €1.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of D. Western Therapeutics Institute Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in D. Western Therapeutics Institute Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €33.70. Based on the TTM, the Book Value Change Per Share is €-15.63 per quarter. Based on the YOY, the Book Value Change Per Share is €-4.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of D. Western Therapeutics Institute Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.14-10.2%-0.14-10.2%-0.07-5.4%-0.05-3.8%-0.08-6.1%
Usd Book Value Change Per Share-16.31-1,217.4%-16.31-1,217.4%-4.44-331.5%-0.11-8.3%0.9571.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-16.31-1,217.4%-16.31-1,217.4%-4.44-331.5%-0.11-8.3%0.9571.2%
Usd Price Per Share0.84-0.84-1.83-2.31-2.91-
Price to Earnings Ratio-6.17--6.17--25.40-18.57--10.99-
Price-to-Total Gains Ratio-0.05--0.05--0.41-0.19-0.09-
Price to Book Ratio0.02-0.02-0.04-0.05-0.06-
Price-to-Total Gains Ratio-0.05--0.05--0.41-0.19-0.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.398156
Number of shares715
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-16.31-0.11
Usd Total Gains Per Share-16.31-0.11
Gains per Quarter (715 shares)-11,663.56-79.90
Gains per Year (715 shares)-46,654.24-319.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-46654-466640-320-330
20-93308-933180-639-650
30-139963-1399720-959-970
40-186617-1866260-1278-1290
50-233271-2332800-1598-1610
60-279925-2799340-1918-1930
70-326580-3265880-2237-2250
80-373234-3732420-2557-2570
90-419888-4198960-2876-2890
100-466542-4665500-3196-3210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.08.00.011.1%1.010.00.09.1%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.05.00.044.4%5.06.00.045.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.011.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.05.00.044.4%5.06.00.045.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of D. Western Therapeutics Institute Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---15.634-15.6340%-4.257-73%-0.107-99%0.915-1809%
Book Value Per Share--33.70033.7000%49.334-32%46.137-27%50.163-33%
Current Ratio--11.02011.0200%12.602-13%11.175-1%25.873-57%
Debt To Asset Ratio--0.4610.4610%0.366+26%0.300+54%0.241+91%
Debt To Equity Ratio--0.8550.8550%0.583+47%0.465+84%0.373+129%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---1063035964.000-1063035964.0000%-1016444400.000-4%-666145332.000-37%-490839080.889-54%
Eps---0.130-0.1300%-0.069-47%-0.049-62%-0.078-40%
Ev To Ebitda Ratio--infinfnan%426.433inf%infnan%nannan%
Ev To Sales Ratio---406.823-406.8230%-371.859-9%-252.582-38%-185.351-54%
Free Cash Flow Per Share---15.846-15.8460%-9.601-39%-6.274-60%-9.569-40%
Free Cash Flow To Equity Per Share---15.846-15.8460%13.230-220%2.400-760%1.464-1182%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---65.520--------
Intrinsic Value_10Y_min---197.409--------
Intrinsic Value_1Y_max---6.351--------
Intrinsic Value_1Y_min---12.636--------
Intrinsic Value_3Y_max---19.246--------
Intrinsic Value_3Y_min---44.379--------
Intrinsic Value_5Y_max---32.338--------
Intrinsic Value_5Y_min---82.910--------
Market Cap50886768.000+40%30570036.00030570036.0000%66456600.000-54%84115068.000-64%105950808.000-71%
Net Profit Margin---1.897-1.8970%-0.959-49%-0.752-60%-2.093+10%
Operating Margin----0%-0.6830%-0.3290%-1.4880%
Operating Ratio--2.9502.9500%1.744+69%1.759+68%2.751+7%
Pb Ratio0.040+40%0.0240.0240%0.035-33%0.052-54%0.061-61%
Pe Ratio-10.268-66%-6.169-6.1690%-25.395+312%18.568-133%-10.985+78%
Price Per Share1.340+40%0.8050.8050%1.750-54%2.215-64%2.790-71%
Price To Free Cash Flow Ratio-0.085-66%-0.051-0.0510%-0.182+259%0.036-240%-0.030-40%
Price To Total Gains Ratio-0.086-66%-0.051-0.0510%-0.411+698%0.188-127%0.091-156%
Quick Ratio--0.6040.6040%0.809-25%0.585+3%2.472-76%
Return On Assets---0.002-0.0020%-0.001-58%-0.001-66%-0.001-44%
Return On Equity---0.004-0.0040%-0.001-64%-0.001-69%-0.002-55%
Total Gains Per Share---15.634-15.6340%-4.257-73%-0.107-99%0.915-1809%
Usd Book Value--1335306801.0001335306801.0000%1954783815.000-32%1828112968.200-27%1987630047.000-33%
Usd Book Value Change Per Share---16.313-16.3130%-4.442-73%-0.112-99%0.954-1809%
Usd Book Value Per Share--35.16335.1630%51.475-32%48.140-27%52.340-33%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---1109171724.838-1109171724.8380%-1060558086.960-4%-695056039.409-37%-512141496.999-54%
Usd Eps---0.136-0.1360%-0.072-47%-0.051-62%-0.082-40%
Usd Free Cash Flow---627875340.600-627875340.6000%-380406945.600-39%-248601944.760-60%-294907271.600-53%
Usd Free Cash Flow Per Share---16.534-16.5340%-10.017-39%-6.546-60%-9.985-40%
Usd Free Cash Flow To Equity Per Share---16.534-16.5340%13.804-220%2.504-760%1.528-1182%
Usd Market Cap53095253.731+40%31896775.56231896775.5620%69340816.440-54%87765661.951-64%110549073.067-71%
Usd Price Per Share1.398+40%0.8400.8400%1.826-54%2.311-64%2.911-71%
Usd Profit---5170784.788-5170784.7880%-2734833.307-47%-1952692.048-62%-3108799.970-40%
Usd Revenue--2726425.4852726425.4850%2852039.994-4%2834856.469-4%2123669.756+28%
Usd Total Gains Per Share---16.313-16.3130%-4.442-73%-0.112-99%0.954-1809%
 EOD+5 -3MRQTTM+0 -0YOY+3 -335Y+5 -3010Y+5 -30

3.3 Fundamental Score

Let's check the fundamental score of D. Western Therapeutics Institute Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.268
Price to Book Ratio (EOD)Between0-10.040
Net Profit Margin (MRQ)Greater than0-1.897
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.604
Current Ratio (MRQ)Greater than111.020
Debt to Asset Ratio (MRQ)Less than10.461
Debt to Equity Ratio (MRQ)Less than10.855
Return on Equity (MRQ)Greater than0.15-0.004
Return on Assets (MRQ)Greater than0.05-0.002
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of D. Western Therapeutics Institute Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5084.570
Ma 20Greater thanMa 500.634
Ma 50Greater thanMa 1000.459
Ma 100Greater thanMa 2000.415
OpenGreater thanClose1.340
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About D. Western Therapeutics Institute Inc

D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch endothelial corneal dystrophy which is in Phase III clinical trials; and H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension. The company was founded in 1999 and is headquartered in Nagoya, Japan.

Fundamental data was last updated by Penke on 2024-12-21 11:21:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit D. Western Therapeutics Institute Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -189.7% means that €-1.90 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of D. Western Therapeutics Institute Inc:

  • The MRQ is -189.7%. The company is making a huge loss. -2
  • The TTM is -189.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-189.7%TTM-189.7%0.0%
TTM-189.7%YOY-95.9%-93.8%
TTM-189.7%5Y-75.2%-114.4%
5Y-75.2%10Y-209.3%+134.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-189.7%-108.6%-81.1%
TTM-189.7%-216.4%+26.7%
YOY-95.9%-207.4%+111.5%
5Y-75.2%-343.0%+267.8%
10Y-209.3%-464.5%+255.2%
4.3.1.2. Return on Assets

Shows how efficient D. Western Therapeutics Institute Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • -0.2% Return on Assets means that D. Western Therapeutics Institute Inc generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of D. Western Therapeutics Institute Inc:

  • The MRQ is -0.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-0.2%0.0%
TTM-0.2%YOY-0.1%-0.1%
TTM-0.2%5Y-0.1%-0.1%
5Y-0.1%10Y-0.1%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-11.5%+11.3%
TTM-0.2%-11.9%+11.7%
YOY-0.1%-11.2%+11.1%
5Y-0.1%-12.6%+12.5%
10Y-0.1%-14.2%+14.1%
4.3.1.3. Return on Equity

Shows how efficient D. Western Therapeutics Institute Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • -0.4% Return on Equity means D. Western Therapeutics Institute Inc generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of D. Western Therapeutics Institute Inc:

  • The MRQ is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM-0.4%0.0%
TTM-0.4%YOY-0.1%-0.2%
TTM-0.4%5Y-0.1%-0.3%
5Y-0.1%10Y-0.2%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-14.3%+13.9%
TTM-0.4%-15.9%+15.5%
YOY-0.1%-14.6%+14.5%
5Y-0.1%-18.3%+18.2%
10Y-0.2%-19.1%+18.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of D. Western Therapeutics Institute Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient D. Western Therapeutics Institute Inc is operating .

  • Measures how much profit D. Western Therapeutics Institute Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of D. Western Therapeutics Institute Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-68.3%+68.3%
TTM-5Y-32.9%+32.9%
5Y-32.9%10Y-148.8%+115.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM--314.9%+314.9%
YOY-68.3%-216.9%+148.6%
5Y-32.9%-374.7%+341.8%
10Y-148.8%-475.8%+327.0%
4.3.2.2. Operating Ratio

Measures how efficient D. Western Therapeutics Institute Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.95 means that the operating costs are €2.95 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of D. Western Therapeutics Institute Inc:

  • The MRQ is 2.950. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.950. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.950TTM2.9500.000
TTM2.950YOY1.744+1.206
TTM2.9505Y1.759+1.191
5Y1.75910Y2.751-0.992
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9502.183+0.767
TTM2.9503.220-0.270
YOY1.7443.262-1.518
5Y1.7594.696-2.937
10Y2.7516.426-3.675
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of D. Western Therapeutics Institute Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if D. Western Therapeutics Institute Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.02 means the company has €11.02 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of D. Western Therapeutics Institute Inc:

  • The MRQ is 11.020. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.020. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.020TTM11.0200.000
TTM11.020YOY12.602-1.582
TTM11.0205Y11.175-0.155
5Y11.17510Y25.873-14.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0203.601+7.419
TTM11.0203.873+7.147
YOY12.6024.655+7.947
5Y11.1755.973+5.202
10Y25.8736.215+19.658
4.4.3.2. Quick Ratio

Measures if D. Western Therapeutics Institute Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.60 means the company can pay off €0.60 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of D. Western Therapeutics Institute Inc:

  • The MRQ is 0.604. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.604. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.604TTM0.6040.000
TTM0.604YOY0.809-0.205
TTM0.6045Y0.585+0.019
5Y0.58510Y2.472-1.887
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6043.104-2.500
TTM0.6043.392-2.788
YOY0.8094.304-3.495
5Y0.5855.954-5.369
10Y2.4726.458-3.986
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of D. Western Therapeutics Institute Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of D. Western Therapeutics Institute Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare D. Western Therapeutics Institute Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.46 means that D. Western Therapeutics Institute Inc assets are financed with 46.1% credit (debt) and the remaining percentage (100% - 46.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of D. Western Therapeutics Institute Inc:

  • The MRQ is 0.461. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.461. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.461TTM0.4610.000
TTM0.461YOY0.366+0.094
TTM0.4615Y0.300+0.161
5Y0.30010Y0.241+0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4610.345+0.116
TTM0.4610.346+0.115
YOY0.3660.310+0.056
5Y0.3000.365-0.065
10Y0.2410.382-0.141
4.5.4.2. Debt to Equity Ratio

Measures if D. Western Therapeutics Institute Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 85.5% means that company has €0.85 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of D. Western Therapeutics Institute Inc:

  • The MRQ is 0.855. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.855. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.855TTM0.8550.000
TTM0.855YOY0.583+0.272
TTM0.8555Y0.465+0.389
5Y0.46510Y0.373+0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8550.393+0.462
TTM0.8550.432+0.423
YOY0.5830.382+0.201
5Y0.4650.452+0.013
10Y0.3730.495-0.122
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings D. Western Therapeutics Institute Inc generates.

  • Above 15 is considered overpriced but always compare D. Western Therapeutics Institute Inc to the Biotechnology industry mean.
  • A PE ratio of -6.17 means the investor is paying €-6.17 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of D. Western Therapeutics Institute Inc:

  • The EOD is -10.268. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.169. Based on the earnings, the company is expensive. -2
  • The TTM is -6.169. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.268MRQ-6.169-4.100
MRQ-6.169TTM-6.1690.000
TTM-6.169YOY-25.395+19.227
TTM-6.1695Y18.568-24.737
5Y18.56810Y-10.985+29.553
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.268-2.033-8.235
MRQ-6.169-2.567-3.602
TTM-6.169-3.171-2.998
YOY-25.395-3.244-22.151
5Y18.568-5.993+24.561
10Y-10.985-6.717-4.268
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of D. Western Therapeutics Institute Inc:

  • The EOD is -0.085. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.051. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.051. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.085MRQ-0.051-0.034
MRQ-0.051TTM-0.0510.000
TTM-0.051YOY-0.182+0.131
TTM-0.0515Y0.036-0.087
5Y0.03610Y-0.030+0.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.085-2.693+2.608
MRQ-0.051-3.295+3.244
TTM-0.051-3.689+3.638
YOY-0.182-4.477+4.295
5Y0.036-8.054+8.090
10Y-0.030-9.219+9.189
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of D. Western Therapeutics Institute Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.02 means the investor is paying €0.02 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of D. Western Therapeutics Institute Inc:

  • The EOD is 0.040. Based on the equity, the company is cheap. +2
  • The MRQ is 0.024. Based on the equity, the company is cheap. +2
  • The TTM is 0.024. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.040MRQ0.024+0.016
MRQ0.024TTM0.0240.000
TTM0.024YOY0.035-0.012
TTM0.0245Y0.052-0.028
5Y0.05210Y0.061-0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0401.878-1.838
MRQ0.0242.070-2.046
TTM0.0242.389-2.365
YOY0.0352.454-2.419
5Y0.0523.716-3.664
10Y0.0614.373-4.312
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Long-term Assets Other  7,4034847,887-9126,9752,1429,117-11,728-2,611



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets2,373,371
Total Liabilities1,093,606
Total Stockholder Equity1,279,765
 As reported
Total Liabilities 1,093,606
Total Stockholder Equity+ 1,279,765
Total Assets = 2,373,371

Assets

Total Assets2,373,371
Total Current Assets2,137,959
Long-term Assets235,410
Total Current Assets
Cash And Cash Equivalents 1,867,264
Net Receivables 117,144
Inventory 87,863
Other Current Assets 65,688
Total Current Assets  (as reported)2,137,959
Total Current Assets  (calculated)2,137,959
+/-0
Long-term Assets
Property Plant Equipment 10,010
Intangible Assets 86,510
Long-term Assets  (as reported)235,410
Long-term Assets  (calculated)96,520
+/- 138,890

Liabilities & Shareholders' Equity

Total Current Liabilities194,008
Long-term Liabilities899,598
Total Stockholder Equity1,279,765
Total Current Liabilities
Short Long Term Debt 9,524
Other Current Liabilities 11,414
Total Current Liabilities  (as reported)194,008
Total Current Liabilities  (calculated)20,938
+/- 173,070
Long-term Liabilities
Long term Debt 875,598
Long-term Liabilities Other 24,000
Long-term Liabilities  (as reported)899,598
Long-term Liabilities  (calculated)899,598
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)1,279,765
Total Stockholder Equity (calculated)0
+/- 1,279,765
Other
Capital Stock831,617
Common Stock Shares Outstanding 32,128
Net Invested Capital 2,164,887
Net Working Capital 1,943,951
Property Plant and Equipment Gross 111,393



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312010-12-312009-12-31
> Total Assets 
1,412,182
990,886
2,140,000
2,912,795
2,877,489
2,073,753
1,981,349
2,737,711
2,462,860
2,956,376
2,373,371
2,373,3712,956,3762,462,8602,737,7111,981,3492,073,7532,877,4892,912,7952,140,000990,8861,412,182
   > Total Current Assets 
1,386,475
969,388
2,024,000
2,776,000
2,515,000
1,764,000
1,715,000
2,503,000
2,162,000
2,659,000
2,137,959
2,137,9592,659,0002,162,0002,503,0001,715,0001,764,0002,515,0002,776,0002,024,000969,3881,386,475
       Cash And Cash Equivalents 
672,719
242,692
1,747,000
2,291,934
2,132,677
1,584,282
1,540,784
2,308,210
1,933,743
2,334,668
1,867,264
1,867,2642,334,6681,933,7432,308,2101,540,7841,584,2822,132,6772,291,9341,747,000242,692672,719
       Short-term Investments 
700,000
720,020
182,000
353,089
0
0
0
0
0
0
0
0000000353,089182,000720,020700,000
       Net Receivables 
8,308
1,855
22,000
36,000
61,000
70,000
103,000
91,877
101,674
170,755
117,144
117,144170,755101,67491,877103,00070,00061,00036,00022,0001,8558,308
       Inventory 
614
624
0
57,000
46,000
59,000
59,000
58,000
88,000
79,000
87,863
87,86379,00088,00058,00059,00059,00046,00057,0000624614
       Other Current Assets 
110
48
73,000
39,000
276,000
51,000
13,000
46,000
40,000
76,000
65,688
65,68876,00040,00046,00013,00051,000276,00039,00073,00048110
   > Long-term Assets 
0
0
0
136,452
361,900
309,295
265,565
234,425
300,674
297,302
235,410
235,410297,302300,674234,425265,565309,295361,900136,452000
       Property Plant Equipment 
15,476
11,750
4,000
25,000
15,000
4,000
3,128
5,292
4,567
10,105
10,010
10,01010,1054,5675,2923,1284,00015,00025,0004,00011,75015,476
       Long Term Investments 
0
0
109,000
109,000
16,000
12,000
12,000
0
0
0
0
000012,00012,00016,000109,000109,00000
       Intangible Assets 
718
535
1,000
1,383
330,343
291,944
249,911
208,254
166,619
124,529
86,510
86,510124,529166,619208,254249,911291,944330,3431,3831,000535718
       Long-term Assets Other 
0
0
0
8,894
5,170
7,403
7,403
7,887
6,975
9,117
-2,611
-2,6119,1176,9757,8877,4037,4035,1708,894000
> Total Liabilities 
26,700
23,710
29,000
35,535
781,620
773,652
573,266
573,806
427,723
1,082,901
1,093,606
1,093,6061,082,901427,723573,806573,266773,652781,62035,53529,00023,71026,700
   > Total Current Liabilities 
26,700
23,709
27,000
35,000
156,000
268,000
189,000
209,000
193,000
211,000
194,008
194,008211,000193,000209,000189,000268,000156,00035,00027,00023,70926,700
       Short-term Debt 
0
0
0
0
600,000
120,000
120,000
0
0
0
0
0000120,000120,000600,0000000
       Short Long Term Debt 
0
0
0
0
600,000
120,000
120,000
120,000
129,524
120,000
9,524
9,524120,000129,524120,000120,000120,000600,0000000
       Accounts payable 
12,877
11,721
0
9,653
0
0
0
0
41,759
0
0
0041,75900009,653011,72112,877
       Other Current Liabilities 
8,292
5,995
27,000
35,000
156,000
148,000
69,000
89,000
64,000
91,000
11,414
11,41491,00064,00089,00069,000148,000156,00035,00027,0005,9958,292
   > Long-term Liabilities 
0
0
0
1
625,350
505,350
384,001
364,001
234,478
871,694
899,598
899,598871,694234,478364,001384,001505,350625,3501000
       Other Liabilities 
0
1
2,000
1,000
27,000
26,000
24,000
25,000
25,000
27,000
0
027,00025,00025,00024,00026,00027,0001,0002,00010
> Total Stockholder Equity
1,385,482
967,176
1,916,000
2,738,165
2,000,959
1,259,861
1,393,064
2,163,905
2,006,973
1,857,488
1,279,765
1,279,7651,857,4882,006,9732,163,9051,393,0641,259,8612,000,9592,738,1651,916,000967,1761,385,482
   Common Stock
1,279,307
1,279,352
2,400,000
2,945,000
3,365,000
34,000
34,000
556,000
573,000
714,000
0
0714,000573,000556,00034,00034,0003,365,0002,945,0002,400,0001,279,3521,279,307
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
0
29,000
15,000
1,000
0
1,000
3,000
2,000
-1,000
0
0-1,0002,0003,0001,00001,00015,00029,00000



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in JPY. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue428,364
Cost of Revenue-36,666
Gross Profit391,697391,698
 
Operating Income (+$)
Gross Profit391,697
Operating Expense-1,226,921
Operating Income-798,558-835,224
 
Operating Expense (+$)
Research Development930,506
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense1,226,921930,506
 
Net Interest Income (+$)
Interest Income10
Interest Expense-2,490
Other Finance Cost-1,396
Net Interest Income-3,876
 
Pretax Income (+$)
Operating Income-798,558
Net Interest Income-3,876
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-826,803-798,558
EBIT - interestExpense = -2,490
-812,411
-809,921
Interest Expense2,490
Earnings Before Interest and Taxes (EBIT)--824,313
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-826,803
Tax Provision-1,595
Net Income From Continuing Ops-828,398-828,398
Net Income-812,411
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-3,876
 

Technical Analysis of D. Western Therapeutics Institute Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of D. Western Therapeutics Institute Inc. The general trend of D. Western Therapeutics Institute Inc is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine D. Western Therapeutics Institute Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of D. Western Therapeutics Institute Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.35 < 1.35 < 1.42.

The bearish price targets are: 1.33 > 1.32 > 1.31.

Tweet this
D. Western Therapeutics Institute Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of D. Western Therapeutics Institute Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

D. Western Therapeutics Institute Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of D. Western Therapeutics Institute Inc. The current macd is 0.18102543.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the D. Western Therapeutics Institute Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for D. Western Therapeutics Institute Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the D. Western Therapeutics Institute Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
D. Western Therapeutics Institute Inc Daily Moving Average Convergence/Divergence (MACD) ChartD. Western Therapeutics Institute Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of D. Western Therapeutics Institute Inc. The current adx is 41.66.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy D. Western Therapeutics Institute Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
D. Western Therapeutics Institute Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of D. Western Therapeutics Institute Inc. The current sar is 0.534528.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
D. Western Therapeutics Institute Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of D. Western Therapeutics Institute Inc. The current rsi is 84.57. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
D. Western Therapeutics Institute Inc Daily Relative Strength Index (RSI) ChartD. Western Therapeutics Institute Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of D. Western Therapeutics Institute Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the D. Western Therapeutics Institute Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
D. Western Therapeutics Institute Inc Daily Stochastic Oscillator ChartD. Western Therapeutics Institute Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of D. Western Therapeutics Institute Inc. The current cci is 239.63.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
D. Western Therapeutics Institute Inc Daily Commodity Channel Index (CCI) ChartD. Western Therapeutics Institute Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of D. Western Therapeutics Institute Inc. The current cmo is 75.64.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
D. Western Therapeutics Institute Inc Daily Chande Momentum Oscillator (CMO) ChartD. Western Therapeutics Institute Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of D. Western Therapeutics Institute Inc. The current willr is -3.26086957.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
D. Western Therapeutics Institute Inc Daily Williams %R ChartD. Western Therapeutics Institute Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of D. Western Therapeutics Institute Inc. The current atr is 0.07827134.

D. Western Therapeutics Institute Inc Daily Average True Range (ATR) ChartD. Western Therapeutics Institute Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of D. Western Therapeutics Institute Inc. The current obv is -22,350.

D. Western Therapeutics Institute Inc Daily On-Balance Volume (OBV) ChartD. Western Therapeutics Institute Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of D. Western Therapeutics Institute Inc. The current mfi is 57.07.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
D. Western Therapeutics Institute Inc Daily Money Flow Index (MFI) ChartD. Western Therapeutics Institute Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for D. Western Therapeutics Institute Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-05 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-19 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-24 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-28 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-07 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-12 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-02 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-03 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-06 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-17 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

D. Western Therapeutics Institute Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of D. Western Therapeutics Institute Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5084.570
Ma 20Greater thanMa 500.634
Ma 50Greater thanMa 1000.459
Ma 100Greater thanMa 2000.415
OpenGreater thanClose1.340
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of D. Western Therapeutics Institute Inc with someone you think should read this too:
  • Are you bullish or bearish on D. Western Therapeutics Institute Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about D. Western Therapeutics Institute Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about D. Western Therapeutics Institute Inc

I send you an email if I find something interesting about D. Western Therapeutics Institute Inc.


Comments

How you think about this?

Leave a comment

Stay informed about D. Western Therapeutics Institute Inc.

Receive notifications about D. Western Therapeutics Institute Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.